Best of the AUA 2002: Stone disease

Presented by Dean G. Assimos, MD, Wake Forest University School of Medicine, Winston-Salem, NC.

Related Content:

Drug TherapyCosmetic Surgery

Pivotal data for lumasiran in PH1 published in NEJM

Nedosiran explored in primary hyperoxaluria type 3

Enrollment completed in pivotal trial of nedosiran for hyperoxaluria